Skip to main content
Log in

A Review of Quality of Life in Alzheimer’s Disease

Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Greer M, Monteban H. A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects [letter]. Pharmacoeconomics 1999; 15 (6): 641

    Article  PubMed  CAS  Google Scholar 

  2. Walker MD, Salek SS, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 1: issues in assessing disease impact. Pharmacoeconomics 1998; 14 (5): 499–530

    Article  PubMed  CAS  Google Scholar 

  3. Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 2: issues in assessing drug effects. Pharmacoeconomics 1998; 14 (6): 613–27

    Article  PubMed  CAS  Google Scholar 

  4. Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects [letter]. Pharmacoeconomics 1999; 15: 641–4

    Article  Google Scholar 

  5. Whiteneck GG. Measuring what matters: key rehabilitation outcomes. Arch Phys Med Rehabil 1994; 75: 1073–6

    Article  PubMed  CAS  Google Scholar 

  6. Gill TM, Feinstein AR. A critical appraisal of the quality of quality of life measurements. JAMA 1994; 272: 619–25

    Article  PubMed  CAS  Google Scholar 

  7. Heinemann AW, Whiteneck GG. Relationships among impairment, disability, handicap and life satisfaction in persons with traumatic brain injury. J Head Trauma Rehabil 1995; 10: 54–63

    Article  Google Scholar 

  8. Doward LC, McKenna SP. Evolution of quality of life assessment. In: Rajagopalan R, Sheretz EF, Anderson RT, editoris. Care management of skin diseases: life quality and economic impact. New York: Marcel Dekker, 1997: 9–33

    Google Scholar 

  9. Doward LC. The development of the Alzheimer’s Carers’ Quality of Life Instrument (ACQLI) [abstract no. 88]. Qual Life Res 1997; 6 Suppl. 7–8: 639

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKenna, S.P., Doward, L.C. A Review of Quality of Life in Alzheimer’s Disease. Pharmacoeconomics 16, 417 (1999). https://doi.org/10.2165/00019053-199916040-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199916040-00009

Keywords

Navigation